Showing posts with label peripheral. Show all posts
Showing posts with label peripheral. Show all posts

Friday, September 27, 2013

0 IL-17-producing peripheral blood CD117+ neutrophils increase in allergic asthmatic subjects

Open Access


Research


IL-17-producing peripheral blood CD117+ neutrophils increase in allergic asthmatic subjects



Carlos Ramirez-Velazquez, Elena Cristina Castillo, Leopoldo Guido-Bayardo and Vianney Ortiz-Navarrete










For all author emails, please log on.








Allergy, Asthma & Clinical Immunology 2013, 9:23 doi:10.1186/1710-1492-9-23

Published: 3 July 2013





Abstract (provisional)


Background


A T helper cell (TH) 17-biased response has been observed in patients with allergic asthma, particularly in those with neutrophil accumulation in the lung. Therefore, we sought to test the hypothesis that neutrophils might be an important source of interleukin (IL)-17 in allergic asthma.

Methods


Whole peripheral blood cells from non-asthmatic control subjects (n = 17) and patients with mild asthma (n = 7), moderate but persistent asthma (n = 4), or acute asthma (n = 6) were analyzed for IL-17A expression in CD177+ neutrophils. IL-17A expression was also analyzed in CD3+CD4+ and CD3+CD8+ lymphocyte populations. Asthmatic patients were classified as allergic to fungi, indoor allergens, or other allergens (e.g., pollen) based on a positive intradermal allergy test reaction.

Results


The percentage of CD177+ neutrophils in whole blood of asthmatic patients was higher than in healthy controls and highest in the moderate asthma group. Furthermore, the percentage of CD177+IL-17+ neutrophils was elevated in patients with mild asthma, whereas the CD4+ IL-17+ lymphocyte population was higher in asthmatic patients and highest in those with moderate but persistent asthma. We also found that the four patients that were allergic to fungi had the highest percentage of CD177+IL17+ neutrophils and CD8+IL17+ lymphocytes.

Conclusion


IL17+CD177+ Neutrophils increase in allergic asthma patients especially when allergic to fungi. This cell population, through release of IL-17, might be contributing during the initial phase asthmatic disease and/or during disease progression but its role has not yet been established






The complete article is available as a provisional PDF. The fully formatted PDF and HTML versions are in production.



Monday, September 16, 2013

0 Mechanisms of peripheral tolerance to allergens










Keywords:




  • allergy;

  • dendritic cells;

  • peripheral tolerance;

  • T helper cells;

  • T regulatory cells






Abstract




The immune system is regulated to protect the host from exaggerated stimulatory signals establishing a state of tolerance in healthy individuals. The disequilibrium in immune regulatory vs effector mechanisms results in allergic or autoimmune disorders in genetically predisposed subjects under certain environmental conditions. As demonstrated in allergen-specific immunotherapy and in the healthy immune response to high-dose allergen exposure models in humans, T regulatory cells are essential in the suppression of Th2-mediated inflammation, maintenance of immune tolerance, induction of the two suppressive cytokines interleukin-10 and transforming growth factor-β, inhibition of allergen-specific IgE, and enhancement of IgG4 and IgA. Also, suppression of dendritic cells, mast cells, and eosinophils contributes to the construction of peripheral tolerance to allergens. This review focuses on mechanisms of peripheral tolerance to allergens with special emphasis on recent developments in the area of immune regulation.





Immune responses are strictly regulated to protect the host from exaggerated signals that may cause tissue injury by establishing a state of immune tolerance. Certain environmental and genetic factors disturb this fine balance of immune regulation, leading to diseases such as allergic or autoimmune disorders. Although allergens are ubiquitously distributed in the environment, the normal response to allergens in healthy individuals is either absent or results in antigen-specific immune tolerance [1].



The immune system must recognize pathogenic stimuli and respond appropriately. Under nonallergic conditions, soluble proteins do not induce a vigorous immune response. Sensitization to a specific antigen is a prerequisite for the onset of atopic diseases in predisposed individuals, which is dependent on the potential of the allergen to prime the Th2 cell response in which interleukin-4 (IL) and IL-13 drive immunoglobulin E (IgE) class-switch in B cells [1-3]. An allergen should induce both early- and late-phase clinical reactions.



There are unique functional and structural features of allergens. There are several crossreactivities among allergen families due to IgE and T-cell epitope sharing. Particularly, food allergens possess structural cavities and tunnels that bind ligands for resistance to heat and proteolysis. Also, repetitive structures, aggregates, and glycation increase immunogenicity. A high number of disulfide bonds and occasionally disordered structures designed for protein stability and mobility have been observed [4]. The amount of allergen in the extract, increased transepithelial allergen delivery, activation of airway epithelial cells, and suppression of local defense mechanisms by the allergen or other substances released from the allergen carrier might contribute to the allergenicity of the protein.



Allergy









Wednesday, September 11, 2013

0 Increased number and altered phenotype of lymphatic vessels in peripheral lung compartments of patients with COPD

Open Access


Research


Increased number and altered phenotype of lymphatic vessels in peripheral lung compartments of patients with COPD



Michiko Mori, Cecilia K Andersson, Gerard J Graham, Claes-Göran Löfdahl and Jonas S Erjefält










For all author emails, please log on.








Respiratory Research 2013, 14:65 doi:10.1186/1465-9921-14-65

Published: 11 June 2013





Abstract (provisional)


Background


De novo lymphatic vessel formation has recently been observed in lungs of patients with moderate chronic obstructive pulmonary disease (COPD). However, the distribution of lymphatic vessel changes among the anatomical compartments of diseased lungs is unknown. Furthermore, information regarding the nature of lymphatic vessel alterations across different stages of COPD is missing. This study performs a detailed morphometric characterization of lymphatic vessels in major peripheral lung compartments of patients with different severities of COPD and investigates the lymphatic expression of molecules involved in immune cell trafficking.

Methods


Peripheral lung resection samples obtained from patients with mild (GOLD stage I), moderate-severe (GOLD stage II-III), and very severe (GOLD stage IV) COPD were investigated for podoplanin-immunopositive lymphatic vessels in distinct peripheral lung compartments: bronchioles, pulmonary blood vessels and alveolar walls. Control subjects with normal lung function were divided into never smokers and smokers. Lymphatics were analysed by multiple morphological parameters, as well as for their expression of CCL21 and the chemokine scavenger receptor D6.

Results


The number of lymphatics increased by 133% in the alveolar parenchyma in patients with advanced COPD compared with never-smoking controls (p – 0.05). In patchy fibrotic lesions the number of alveolar lymphatics increased 20-fold from non-fibrotic parenchyma in the same COPD patients. The absolute number of lymphatics per bronchiole and artery was increased in advanced COPD, but numbers were not different after normalization to tissue area. Increased numbers of CCL21- and D6-positive lymphatics were observed in the alveolar parenchyma in advanced COPD compared with controls (p – 0.01). Lymphatic vessels also displayed increased mean levels of immunoreactivity for CCL21 in the wall of bronchioles (p – 0.01) and bronchiole-associated arteries (p – 0.05), as well as the alveolar parenchyma (p < 0.001) in patients with advanced COPD compared with never-smoking controls. A similar increase in lymphatic D6 immunoreactivity was observed in bronchioles (p – 0.05) and alveolar parenchyma (p – 0.01).

Conclusions


This study shows that severe stages of COPD is associated with increased numbers of alveolar lymphatic vessels and a change in lymphatic vessel phenotype in major peripheral lung compartments. This novel histopathological feature is suggested to have important implications for distal lung immune cell traffic in advanced COPD.






The complete article is available as a provisional PDF. The fully formatted PDF and HTML versions are in production.




Tuesday, September 10, 2013

0 Expression of IL-7 receptor in human peripheral regulatory T cells


Logo of ams









Arch Med Sci. 2013 June 20; 9(3): 555–560.

Published online 2012 October 30. doi:  10.5114/aoms.2012.31387




PMCID: PMC3701966





Expression of IL-7 receptor in human peripheral regulatory T cells








Abstract




Introduction


Regulatory T cells (Tregs, CD4 + CD25high Foxp3+) play a crucial role in allergy and other inflammatory diseases. However, the isolation of viable Tregs on the basis of intracellular expression of specific Forkhead Box Protein P3 (Foxp3) is difficult. In this study we checked if the expression of IL-7 receptor (CD127) on the Tregs could be a useful marker for isolation of viable Treg Foxp3+ cells.



Material and methods


Twenty-five patients sensitized to grass pollen with allergic rhinitis (AR) and ten healthy subjects were included. We compared Foxp3 expression in different CD4+ T cell subsets by flow cytometry and we assessed the relationship between the expression of Foxp3 and CD127 within regulatory T cells.



Results


Within the CD4+ lymphocytes 3.68 ±2.0% showed expression of Foxp3, 51.82 ±8.03% of CD4+CD25highwere Foxp3 positive (Foxp3+), whereas 82.12 ±5.4% of CD4+CD25highCD127low were Foxp3+. High intracellular expression of Foxp3 correlated with low superficial CD127 expression (r = 0.42, p = 0.017). There were no significant differences regarding the analysed markers between AR patients and healthy controls.



Conclusions


Regulatory T cells may be purified from the fresh peripheral blood as viable regulatory Foxp3 bright cells using CD4, high expression of CD25 and low expression of CD127 antigen.



Keywords: allergy, cytokines, inflammation, rhinitis, regulatory lymphocytes








Formats: